인쇄하기
취소
|
It was confirmed that Ministry of Health and Welfare is proceeding with administrative action on 'Stillen' ordering restriction of insurance benefit and redemption of 60 billion won amount, because Donga ST didn't submit data for clinical usefulness of Stillen during the limited period.
It seems to be hard to conduct clinical trial of Donga ST for a determined period. Typically, there need suf...